Randomized trial of three anticonvulsant medications for status epilepticus

New England Journal of Medicine

Volumn 381, Issue 22, 2019, Pages 2103-2113

  Kapur, Jaideep ^a   Elm, Jordan ^b   Chamberlain, James M ^c   Barsan, William ^d   Cloyd, James ^e   Lowenstein, Daniel ^f   Shinnar, Shlomo ^g   Conwit, Robin ^h   Meinzer, Caitlyn ^b   Cock, Hannah ⁱ   Fountain, Nathan ^a   Connor, Jason T ^j,k   Silbergleit, Robert ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

^h NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

ⁱ ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^j ConfluenceStat ^*  (United States)

^k UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOSPHENYTOIN SODIUM; LEVETIRACETAM; VALPROIC ACID; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; PHENYTOIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; CONSCIOUSNESS LEVEL; CONVULSION; DRUG RESPONSE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOGENIC NONEPILEPTIC SEIZURE; RESPIRATORY DISTRESS; SCHOOL CHILD; YOUNG ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTICONVULSANTS; BENZODIAZEPINES; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; LEVETIRACETAM; MALE; MIDDLE AGED; PHENYTOIN; STATUS EPILEPTICUS; VALPROIC ACID; YOUNG ADULT;

EID: 85075733142     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1905795     Document Type: Article

References (19)

1. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366: 591-600.
2. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345: 631-7.
3. Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA 2014; 311: 1652-60.
4. Cook AM, Castle A, Green A, et al. Practice variations in the management of status epilepticus. Neurocrit Care 2012; 17: 24-30.
5. Riviello JJ Jr, Claassen J, LaRoche SM, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013; 18: 193-200.
6. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23.
7. Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr 2016; 16: 48-61.
8. Gaínza-Lein M, Sánchez Fernández I, Jackson M, et al. Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol 2018; 75: 410-8.
9. Avdic U, Ahl M, Chugh D, et al. Nonconvulsive status epilepticus in rats leads to brain pathology. Epilepsia 2018; 59: 945-58.
10. Shinnar S, Bello JA, Chan S, et al. MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012; 79: 871-7.
11. Connor JT, Elm JJ, Broglio KR. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol 2013; 66: Suppl: S130-S137.
12. CFR - Code of Federal Regulations: 21CFR50.24. Silver Spring, MD: Food and Drug Administration, 2018 (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=50.24).
13. Zhao W, Ciolino J, Palesch Y. Stepforward randomization in multicenter emergency treatment clinical trials. Acad Emerg Med 2010; 17: 659-65.
14. Alvarez V, Januel J-M, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011; 52: 1292-6.
15. Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 2014; 23: 167-74.
16. Tripathi M, Vibha D, Choudhary N, et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure 2010; 19: 109-11.
17. Dalziel SR, Borland ML, Furyk J, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet 2019; 393: 2135-45.
18. Lyttle MD, Rainford NEA, Gamble C, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet 2019; 393: 2125-34.
19. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007; 16: 527-32.